Macoin, Julie, Rami Lissilaa, Pavankumar Sancheti, Venkateshwar Reddy, Jonathan Back, and Gerhard Wolff. “Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S62. Accessed July 23, 2024. https://jofskin.org/33014/index.php/skin/article/view/458.